Remeron Drug Description

HealthCentral.com

Drug Library
Remeron - Drug Description [Mirtazapine]

Remeron (mirtazapine) is an antidepressant, which can be given as treatment for episodes of major depression. The presence of symptoms such as anhedonia, psychomotor inhibition, sleep disturbances (early wakening) and weight loss, increase the chance of a positive response.

Other symptoms are:

loss of interest, suicidal thoughts and changes in mood (better in the evening than in the morning). Remeron begins to exert its effect in general after 1-2 weeks of treatment.

1. NAME OF THE MEDICINAL PRODUCT
Remeron SolTab, 15, 30 and 45 mg orodispersible tablet

2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 15, 30 or 45 mg of mirtazapine. For excipients, see 6.1.

3. PHARMACEUTICAL FORM
Orodispersible tablet
Round, white, standard bevelled-edge tablets marked with a code on one side (TZ/ 1 for 15 mg tablets, TZ/ 2 for 30 mg tablets and TZ/ 4 for 45 mg tablets).

4. CLINICAL PARTICULARS
4.1 Therapeutic indications
Episode of major depression.

4.2 Posology and method of administration
In order to prevent crushing the tablet, do not push against the tablet pocket (Figure A).

PHARMACEUTICAL PARTICULARS

List of excipients

Remeron SolTab 15, 30 and 45 mg tablets contain: Sugar spheres, hydroxypropyl methylcellulose, polyvinylpyrrolidone (povidone), magnesium stearate, aminoalkyl methacrylate copolymer E (Eudragit E100), aspartame, citric acid, crospovidone, mannitol, microcrystalline cellulose, natural and artificial orange flavour and sodium bicarbonate.

6. 2 Incompatibilities
Not applicable.

6.3 Shelf life
2 years.

6.4 Special precautions for storage
Remeron SolTab should be stored in the original package.